Examples of GLP-1 receptor agonists licensed in the UK include semaglutide, dulaglutide, liraglutide, exenatide and lixisenatide
Diabetic neuropathy differs between type 1 and type 2 diabetes: insights from magnetic resonance neurography
OR The patient has a BMI at or above 27 kg/m with a weight-related medical condition such as high blood pressure, sleep apnea, or Type 2 diabetes
Tests that may be necessary to exclude infectious, metabolic and immunologic causes of upper GI symptoms include a complete blood count
Eligibility, Safety, and Expectations Many people searching for GLP-1 weight loss medications want to know whether they may be eligible before speaking with a healthcare provider
Model predicts most lost weight returns within one year The authors retrieved 48 relevant studies involving overweight or obese participants